News
ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Jennifer Lynne Bath - CEO, President & Non-Independent Director Joseph Scheffler - Interim Chief Financial ...
3dOpinion
MedPage Today on MSNThe Rise in Adolescent Bariatric Surgery Doesn't Mean GLP-1s Have FailedWhen glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
“This is the first major study to compare the effect of two common diabetes treatments — GLP-1 medicines and metformin — on dementia risk, using health records from more than 174,000 people. The ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results